AUA
  • Program
  • Register
  • Meeting Coverage
  • Guidelines
  • Industry Highlights
  • Science & Technology Hall
  • Photo Gallery
Topics
  • Meeting Coverage
  • Guidelines
  • Industry Highlights
  • Science & Technology Hall
  • Photo Gallery
Resources
  • Program
  • Register
Twitter X icon Facebook iconInstagram iconYouTube iconLinkedIn icon
Apr 15, 2025

Panel to explore updated vasectomy guidelines

Guideline authors emphasize minimally invasive approaches and post-vasectomy fertility.


Akanksha Mehta, MD, MS
Akanksha Mehta, MD, MS

AUA2025 attendees will get the first public glimpse of the updated vasectomy guidelines during the AUA Annual Meeting in Las Vegas. The mechanics of performing a vasectomy have not changed since the AUA guidelines were first published in 2012, but the social and cultural contexts are different. 

“Vasectomy still remains one of the most utilized outpatient urology procedures,” said Akanksha Mehta, MD, MS, professor of urology at Emory University School of Medicine. “The importance of vasectomy as a male method of contraception has changed given recent changes in the political climate. Discussions around consultations for vasectomy, including who is eligible and who is not, advice for patients who have not previously fathered children, and recommendations regarding fertility potential after vasectomy—all of that is changing dramatically.”

Dr. Mehta will lead “Case-Based Guidelines Panel Discussion: Vasectomy Update,” 2:05-2:35 p.m. on Monday, April 28, in the Venetian Ballroom. The guidelines will be released for public comment after the AUA Annual Meeting, with publication planned for fall 2025.

The initial guidelines, which were amended in 2015, emphasized that there was no single best approach to vasectomy. Approaches varied significantly among clinicians, from bilateral open procedures to minimally invasive no-needle, no-scalpel alternatives, and practitioners were advised to use the approach with which they were the most comfortable. Updated guidelines will likely emphasize minimally invasive approaches that are more efficacious for patients and likely more familiar to more recently trained urologists.

Urologists can also expect two new topics.

One is the first discussion of managing post-vasectomy fertility, either via reversal or sperm extraction plus in vitro fertilization.

The second is the use of at-home or mail-in testing for semen analysis, which was not available when the current guidelines were published. The return rate for post-vasectomy semen analysis is less than 70%, Dr. Mehta noted, which has given some urologists pause.

“This is one of the most litigious procedures in urology,” she said. “If you can optimize clinical outcomes and optimize the chances of a patient completing a post-vasectomy semen analysis test by offering them an at-home or mail-in test, that definitely gives us some peace of mind. 

Guideline authors have also included a discussion of the latest data on the relationship between vasectomy and the incidence of later urologic diseases and conditions. New data suggests that the observed association between vasectomy and subsequent urologic complaints is an artefact of vasectomy patients being more likely to have greater familiarity and comfort with urologists, and more urologic interactions compared to similar patients who have not undergone vasectomy.

Ongoing social and political changes surrounding contraception and abortion are also encouraging more individuals and couples to consider vasectomy. Gone are the days when urologists strictly discouraged vasectomy for those who had not had children or might want children in the future.

“People have vasectomies for all sorts of reasons and personal choices, so tailored counseling for each patient is essential,” Dr. Mehta said. “As reproductive choices become more complex, we are going to see more and more patients lean toward getting a vasectomy. We have to be mindful of these changing trends.”

Interesting Stories
Register for the Career Fair at AUA2025
Sponsored by AUA
Register for the Career Fair at AUA2025
Book your AUA2025 housing now
Sponsored by AUA
Book your AUA2025 housing now
YONSA® (abiraterone acetate) Holds a Full House of Benefits—See Booth 1222
Sponsored by Sun Pharma
YONSA® (abiraterone acetate) Holds a Full House of Benefits—See Booth 1222
More Content
Getty Images 1971521073 (2)
Previews
P2s spotlight groundbreaking clinical trials
Apr 15, 2025
Young Res
Previews
Resident programming fosters skills, camaraderie and leadership
Apr 15, 2025
Melissa R. Kaufman, MD, PhD, FACS
Previews
New guidelines for managing genitourinary syndrome of menopause
Apr 15, 2025
Getty Images 2197045271
Previews
AUA2025 will offer a glimpse into the future of urology
Mar 28, 2025
Patient Perspectives
Previews
Shining a light on Patient Perspectives
Mar 28, 2025
Ashish Kamat, MD
Previews
Contemporary controversies in bladder cancer management
Mar 28, 2025
Li-Ming Su, MD
Previews
Crossfire to explore single versus multiport robotic surgery
Mar 28, 2025
Daniel W. Lin, MD
AUA2023
Experts to debate best uses of PSMA-PET in prostate cancer treatment decisions
Apr 07, 2023
Bowl Winners 02
AUA2023
AUA2023 Annual Meeting in pictures
Apr 07, 2023
Getty Images 1344701426
AUA2023
Residents Forum explores career possibilities in urology
Apr 07, 2023
Getty Images 1438547233
AUA2023
Supporting inclusivity and encouraging diversity in urology
Apr 07, 2023
Getty Images 530686149
AUA2023
Keep your career flow going
Apr 07, 2023
AUA
Twitter X icon Facebook iconInstagram iconYouTube iconLinkedIn icon
© 2025 Ascend Media. All rights reserved.